H. Scheiblauer

H. Scheiblauer, V. Corman, C. Drosten, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus

S. Nick, H. Scheiblauer, A. Prince, 2006, Transfusion.

Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species

A. Kendal, H. Scheiblauer, R. Rott, 2005, Archives of Virology.

Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021

H. Scheiblauer, V. Corman, C. Drosten, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Establishment of an evaluation panel for the decentralized technical evaluation of the sensitivity of 31 rapid detection tests for SARS-CoV-2 diagnostics

H. Scheiblauer, V. Corman, C. Drosten, 2021, medRxiv.

Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests

H. Scheiblauer, V. Corman, C. Drosten, 2021, medRxiv.

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, October 2014 Collaborative Study to Establish the First WHO International Standard for Detection of Hepatitis C Virus Core Antigen

S. Nick, P. Volkers, Stefan Ross, 2014 .

Safety of blood and blood products : test methods for the detection of hepatitis B , C , and E virus

H. Scheiblauer, J. Kress, J. Mitterreiter, 2022 .

International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen.

A. Heath, S. Nick, H. Scheiblauer, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Collaborative Study to Establish a World Health Organization International Standard for Hepatitis B e Antigen (HBeAg)

S. Nick, P. Volkers, H. Scheiblauer, 2013 .

Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes

H. Zeichhardt, S. Nick, H. Scheiblauer, 2010, Vox sanguinis.

Detection of hepatitis B virus infection in German blood donors 2008–2015

H. Scheiblauer, D. Oberle, M. Chudy, 2020, Vox sanguinis.

Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes.

H. Scheiblauer, E. Hildt, D. Glebe, 2017, Virology.

Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015)

H. Scheiblauer, D. Oberle, M. Chudy, 2019, Vox sanguinis.

Report of the WHO collaborative study to establish the First International Standard for detection of antibodies to hepatitis B virus e antigen (anti-HBe)

S. Nick, P. Volkers, H. Scheiblauer, 2013 .

Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany

H. Scheiblauer, A. Nitsche, L. Schaade, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022

S. Ciesek, H. Neuhauser, H. Scheiblauer, 2023, Pathogens.

Comparison of BVDV and SFV Used as Models for Hepatitis C Virus in Virus Validation Studies

J. Löwer, H. Scheiblauer, A. Scheidler, 2001 .